Pseudotumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rituximab in IgG4-RD: A Phase 1-2 Trial (NCT01584388) | Massachusetts General Hospital | 2012-04-01 |
Track Pseudotumor automatically
Every clearance here is in the API, with alerts when new ones post.